Distribuzione geografica
Continente #
NA - Nord America 11828
EU - Europa 2684
AS - Asia 906
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15427
Nazione #
US - Stati Uniti d'America 11824
UA - Ucraina 1666
VN - Vietnam 641
DE - Germania 518
CN - Cina 186
SE - Svezia 180
IT - Italia 150
GB - Regno Unito 103
TR - Turchia 53
FR - Francia 21
IN - India 15
IE - Irlanda 14
FI - Finlandia 9
CZ - Repubblica Ceca 8
RO - Romania 5
EU - Europa 4
AT - Austria 3
BR - Brasile 3
CA - Canada 3
JP - Giappone 2
NL - Olanda 2
PH - Filippine 2
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MX - Messico 1
MY - Malesia 1
PK - Pakistan 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SG - Singapore 1
SI - Slovenia 1
Totale 15427
Città #
Fairfield 2751
Woodbridge 1299
Seattle 1085
Ashburn 1075
Wilmington 1034
Houston 1023
Cambridge 937
Jacksonville 885
Princeton 652
Ann Arbor 404
Dong Ket 330
San Diego 221
Beijing 91
Chandler 82
Kocaeli 53
Nyköping 47
Milan 33
Norwalk 23
Redmond 17
Treviglio 17
Kunming 14
Redwood City 12
Hefei 11
Nanjing 10
Chennai 9
Helsinki 9
Brno 8
Shanghai 7
Bergamo 6
Jinan 6
Menlo Park 6
Guangzhou 5
Nanchang 5
Rome 5
San Genesio Ed Uniti 5
Zhengzhou 5
Hebei 4
Leawood 4
London 4
San Francisco 4
Shenyang 4
Wuhan 4
Xian 4
Alleppey 3
Como 3
Fuzhou 3
Lesmo 3
Paris 3
Toronto 3
Vienna 3
Berlin 2
Boardman 2
Chongqing 2
Los Angeles 2
Manila 2
Phoenix 2
San Polo 2
Shaoxing 2
São Paulo 2
Tokyo 2
Almaty 1
Amsterdam 1
Athens 1
Bitonto 1
Borås 1
Boulder 1
Bucaramanga 1
Central District 1
Charleston 1
Colombo 1
Copparo 1
Erba 1
Gazoldo degli Ippoliti 1
Groningen 1
Hangzhou 1
Huzhou 1
Islamabad 1
Kalmar 1
Kuala Lumpur 1
Linköping 1
Lishui 1
Ljubljana 1
Mexico City 1
Nanning 1
New Delhi 1
Pavia 1
Perm 1
Piombino 1
Riyadh 1
San Mateo 1
Singapore 1
Stockholm 1
Taizhou 1
Trescore Balneario 1
Udine 1
Totale 12286
Nome #
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky? 168
How can we use the results of ambulatory blood pressure monitoring in clinical practice? 151
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus 139
Association between periodontal disease and left ventricle mass in essential hypertension 133
Circadian rhythm of pulse pressure in hypertension: Prognostic implications 133
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy 123
Good news for beta-blockers in perioperative medicine 110
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus 99
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy 93
Microcirculation and left-ventricular hypertrophy 89
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke 89
Sudden Cardiac Death in Hypertensive Patients 85
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study 85
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview 82
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives 82
Modernization and hypertension: is the link changing? 82
Hypertension and the J-curve phenomenon: implications for tight blood pressure control 81
The clinical significance of white-coat and masked hypertension 78
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple 78
The optimal blood pressure target for patients with coronary artery disease 78
Angiotensin-converting enzyme inhibitors 76
At the beginning of stiffening - Endothelial dysfunction meets "pulsology" 76
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous? 75
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain 75
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension 75
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome 75
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk 75
Does brachial pulse pressure predict coronary events? 74
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus 74
How important is to reduce sodium and increase potassium in patients with hypertension? 74
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? 73
Ambulatory blood pressure for cardiovascular risk stratification 73
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection 73
Estimate of white-coat effect and arterial stiffness 72
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk 72
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease 72
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase? 70
White-coat hypertension in adults 69
Improved cardiovascular risk stratification by a simple ECG index in hypertension 69
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension 69
The emerging role of high-density lipoprotein cholesterol in hypertension trials 68
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects 68
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol? 67
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension Prognostic Implications 67
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement 67
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications 67
Angiotensin-converting enzyme inhibitors 66
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis 66
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies 66
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension 66
Risk of stroke in white-coat hypertension: A multinational registry 66
Atrial fibrillation in hypertension - Predictors and outcome 65
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension 65
Adverse prognostic significance of new diabetes in treated hypertensive subjects 65
Prognostic value of serial Electrocardiographic voltage and repolarization changes in essential hypertension: The HEART survey study 65
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy 64
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis 64
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age 64
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet? 64
Hypertension, inflammation and atrial fibrillation 64
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation 64
Electrocardiographic abnormalities of left ventricular repolarization: Prognostic implications in hypertensive post-menopausal women 64
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both 63
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 63
Natural history of hypertension subtypes 63
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment 63
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions 63
Do angiotensin II receptor blockers increase the risk of myocardial infarction? 63
Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories 63
The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease 63
Blood pressure lowering in diabetic patients 63
New-onset diabetes in treated hypertensive patients 63
Severity of COVID-19: The importance of being hypertensive 63
Role of ambulatory blood pressure monitoring in prehypertension 62
Clinical significance of the blood pressure changes from day to night 62
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? 62
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis 62
Validation of the A&D UA-705 device for self-measurement of blood pressure according to the British Hypertension Society protocol 62
Telmisartan for the reduction of cardiovascular morbidity and mortality 62
New-onset diabetes, antihypertensive treatment, and outcome 62
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers 61
Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects 61
Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome 61
Short- and long-term incidence of stroke in white-coat hypertension 61
Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: A meta-analysis 61
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention 61
Improved performance of traditional ECG for diagnosis of left ventricular hypertrophy in hypertension 61
Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes 61
Hypertension and Atrial Fibrillation Doubts and Certainties From Basic and Clinical Studies 60
Glucose Lowering, Hypoglycemia, and Cardiovascular Disease Risk 60
Clinical usefulness of ambulatory blood pressure monitoring 60
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring 60
Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation 60
Validation of the A & D UA-774 (UA-767Plus) device for self-measurement of blood pressure 60
Asymptomatic left ventricular systolic dysfunction in essential hypertension - Prevalence, determinants, and prognostic value 60
The natural history of white-coat hypertension in the long term 59
Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension 59
Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study 59
Totale 7338
Categoria #
all - tutte 26612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26612

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205188 0000 0678 12821082 820558195573
2020/20217218 551246354937 2061072 268640 728401421890
2021/20222853 2715096189 82120 183221 193444313367
2022/2023530 342778328 00 00 0000
Totale 15789